Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2020-11-10 15:41:24
Innovative and generic & biosimilar pharmaceutical industries unite on commitment to equitable access to COVID-19 medicines and vaccines, while flagging where further help is needed from others
Geneva 10 November 2020 – On the occasion of the World Health Assembly, the world’s research-based and generic & biosimilar ...
Read More2020-10-22 09:38:06
IFPMA launches Note for Guidance to help those acting on behalf of biopharmaceutical companies live up to its ethical business principles
GENEVA, 22 October 2020: The International Association of Pharmaceutical Manufacturers and Associations (IFPMA) published today ...
Read More2020-10-13 12:00:39
IFPMA applauds APEC for trailblazing efforts to demonstrate return on ethics for SMEs through Vision 2025
GENEVA, 13 October 2020: Today, IFPMA joined hundreds of diverse stakeholders from more than 30 ...
Read More2020-09-21 12:00:07
Innovative vaccine and medicine industry applaud country commitments to COVAX Facility
Vaccine makers, and biopharmaceutical industry more generally, are encouraged to see the broad international support ...
Read More2020-09-03 09:29:26
Biopharma industry updates on COVID-19 treatments progress and warns about upholding regulatory standards of quality
Geneva, 3 September 2020 – Seven months into the pandemic, the innovative biopharmaceutical industry continues ...
Read More2020-07-26 18:16:22
WADA and IFPMA strengthen collaboration in the protection of clean sport
Geneva / Montreal, 28 July 2020: The World Anti-Doping Agency (WADA) and the International Federation ...
Read More2020-07-09 13:30:55
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment of US$1 billion
New AMR Action Fund steps in to save collapsing antibiotic pipeline with pharmaceutical industry investment ...
Read More
Latest Statement
2020-11-20 14:00:59
Biopharmaceutical representative joins new antibiotic resistance fighting United Nations group to avert looming superbugs public health
20 November 2020, The World Health Organization, the Food and Agriculture Organization and the World Organization for Animal Health announced ...
Read More2020-11-18 10:00:15
Joint Statement On World Antimicrobial Awareness Week
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More2020-11-09 21:42:14
IFPMA/IGBA “Considerations on equitable access to COVID-19 medicines and vaccines”
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More2020-11-09 20:41:39
IFPMA Statement for the resumed 73rd WHA on agenda item 13.3 Influenza preparedness
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More2020-10-16 19:32:12
IFPMA statement on “Intellectual Property and COVID-19”
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More2020-10-13 17:53:39
Biopharmaceutical industry support EU regulators exceptional transparency measures and call other regulatory authorities to follow suit to help ensure confidence in the science and the decision-making
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More2020-10-06 08:58:12
IFPMA Statement for the Special session of the Executive Board on implementation of Resolution WHA73.1
New AMR Action Fund steps in to save collapsing antibiotic ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
HIV and tuberculosis: Ensuring people’s access to treatment during the pandemic
This was originally published on Global Cause on the 2020 HIV & TB Awareness campaign on 1 December 2020. As the global coronavirus pandemic continues, we need to maintain continued access to HIV and TB essential medications worldwide. The COVID-19 pandemic has claimed more than 1.2 million lives, and many more deaths have likely gone unreported. The life science industries, governments, researchers, and numerous public health...
Read More
5 questions to… Cary Adams, CEO of the Union for International Cancer Control (UICC)
For World Antimicrobial Awareness Week (WAAW), Dr Cary Adams shares with us the importance of raising awareness on the growing threat of antimicrobial resistance and how it affects the cancer community. In what circumstances and how often are antibiotics used for cancer treatment and care? The treatment and care of cancer involves a wide range of interventions namely surgery, radiotherapy, chemotherapy, novel targeted therapies, and...
Read More
2020: A game-changing year for AMR?
Dame Sally Davies, UK AMR Special Envoy and Thomas Cueni, IFPMA’s DG have shared platforms on panels. This time at the World AMR Congress, saw the duo in a different format, with Dame Sally pitching questions at Thomas Cueni and asking him if industry has done enough to tackle AMR. Global Health Matters has reproduced the highlights of this lively exchange. [embed]https://youtu.be/qsY7rL-4j-Q[/embed] (Listen to the...
Read MoreLatest Tweets
